GLP-1 medications, known for their role in treating diabetes and obesity, are being studied for additional health benefits, including improvements in heart health and potential cancer risk reduction. Experts highlight the need for further research to understand their full impact…
A recent study published in Diabetologia reveals that the GLP-1 drug dulaglutide is more effective than standard insulin in treating diabetes associated with transfusion-dependent…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
Dr. Loren Rourke, a Texas-based breast surgical oncologist, highlights five everyday habits that may help reduce cancer risk and improve health outcomes. While no lifestyle choice…
Experts advise that individuals taking oral GLP-1 medications like Wegovy should avoid consuming coffee or tea at the same time to ensure proper absorption of the medication. The…
Researchers from East China Normal University have developed a probiotic that can sense and respond to glucose levels, potentially transforming type 2 diabetes treatment. This inn…
A recent study examined how higher-protein meals from plant and animal sources affect blood sugar levels. The findings suggest that while animal protein raises branched-chain amin…
Researchers at the University of Cambridge have discovered that both activating and blocking the glucose-dependent insulinotropic polypeptide receptor (GIPR) in different brain re…
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
A recent study led by Yale researchers explored how Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) affect the ability of patients with type 2 diabetes to discontinue insulin…
A recent study published in The BMJ indicates that tirzepatide, a GLP-1 medication, may lower the risk of major cardiovascular events by 33% in patients with type 2 diabetes and h…
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized orforglipron, making the UK the first country in Europe to approve this GLP-1 tablet for weight manag…
Recent research highlights Alaska pollock protein (APP) as an effective dietary source for promoting skeletal muscle hypertrophy, particularly in fast-twitch fibers. The study dem…